THIRD AMENDMENT TO LICENSE AGREEMENTLicense Agreement • May 15th, 2003 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • Georgia
This Third Amendment to License Agreement (“Third Amendment”) is effective as of the 31st day of May, 2002 (the “Effective Date”), by and among Triangle Pharmaceuticals, Inc., a Delaware corporation with principal offices located at 4 University Place, 4611 University Drive, Durham, North Carolina 27707 (“COMPANY”) and Emory University, a not-for-profit Georgia corporation with offices at 1380 South Oxford Road, N.E., Atlanta, Georgia 30322 (“LICENSOR”), and amends certain terms of that certain License Agreement, dated April 17, 1996, between LICENSOR and COMPANY, as amended by the First Amendment to License Agreement, dated May 6, 1999 (“First Amendment”) and as further amended by the Second Amendment to License Agreement dated July 10, 2000 (“Second Amendment”) (such License Agreement as amended by the First Amendment and the Second Amendment is referred to herein as the “Agreement”).
